UNSPSC 51281650: Gentamicin c1a

This classification denotes an aminoglycoside antibiotic C19H39N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AV4A72IATD, chemically known as d-streptamine, o-3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-.alpha.-d-erythro-hexopyranosyl-(1->4))-2-deoxy-, but more generally known as gentamicin c1a, which bears US NIH Compound Identifier 72396. Most nations, for tariff and trade purposes, schedule gentamicin c1a under HS 29419000 and SITC 54139.

As of Q4 2014, GENTAMICIN C1A remains US FDA's Preferred Term for this commodity. Gentamicin c1a bears US NLM identifiers UMLS ID C1563655 and NCI Concept Code C76149. SMILES: C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N)N)O.

UNSPSC 51281650 Gentamicin c1a, a Commodity code, shows misalignment between its nominal scope and recent state and local procurement activity. The code nominally refers to a specific antibiotic pharmaceutical product, yet the recent opportunities tagged under it encompass naloxone procurement, pharmacy benefit program development, medical and first aid supplies, and generic multi-source pharmaceuticals through cooperative purchasing — none of which involve gentamicin c1a specifically. The code does not reflect what state and local governments are actually buying in the associated solicitations.

The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire and rescue departments (Tampa Fire Department), and cooperative purchasing alliances serving multi-state networks (Minnesota Multistate Cooperative Purchasing Alliance with Oregon participation). Recent opportunities span Florida, Texas, and the Minnesota-Oregon cooperative network, with activity driven by public health initiatives, emergency medical services, and state pharmacy benefit programs. Representative recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone annually, response due July 26, 2023); the City of Tampa's IFB for medical and first aid supplies for the Fire Department Rescue Division (169 line items, estimated contract value $700,000, response due March 13, 2026, with SLBE set-aside and 5 percent discount); the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (response due April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (response due March 26, 2026, effective July 1, 2026). The code shows little relevant recent activity tied to gentamicin c1a itself.